Helix BioPharma (HBP) Stock Chart & Stock Price History C$3.95 +1.04 (+35.74%) As of 10/3/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Helix BioPharma Stock Price Performance The Helix BioPharma (HBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 237.61%, with a year-to-date return of 343.82%. In the past month, the stock has increased 172.41%, reflecting recent market activity. As of the latest close, Helix BioPharma traded at C$3.95 with a market cap of C$301.69 million and volume of 56,753 shares. Five years ago, the stock traded at C$0.35, representing a 1,028.57% increase over that period. At the time, it had a market cap of C$46.53 million and a volume of 6,000 shares. Receive HBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+97.50%1 Month Performance+172.41%3 Month Performance+307.22%Year-To-Date Performance+343.82%1 Year Performance+237.61%5 Year Performance+1,028.57% HBP Stock Chart for Monday, October, 6, 2025 HBP Chart by TradingView Helix BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025C$2.91C$3.95+35.74%C$4.25C$2.7856,753 shsC$301.69 million10/02/2025C$2.00C$2.91+45.50%C$3.87C$2.3837,292 shsC$222.26 million10/01/2025C$1.69C$2.00+18.34%C$2.00C$1.895,211 shsC$152.76 million09/30/2025C$1.59C$1.69+6.29%C$1.69C$1.5413,000 shsC$129.08 million09/29/2025C$1.59C$1.59C$1.60C$1.591,315 shsC$121.44 million09/26/2025C$1.52C$1.59+4.61%C$1.59C$1.513,264 shsC$121.44 million09/25/2025C$1.59C$1.52-4.40%C$1.55C$1.521,300 shsC$116.10 million09/24/2025C$1.60C$1.59-0.63%C$1.59C$1.58300 shsC$121.44 million09/23/2025C$1.55C$1.60+3.23%C$1.60C$1.49750 shsC$118.39 million09/22/2025C$1.51C$1.55+2.65%C$1.60C$1.495,876 shsC$118.39 million Get the Latest News and Ratings for HBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025C$1.51C$1.51C$1.52C$1.463,080 shsC$115.33 million09/18/2025C$1.50C$1.51+0.67%C$1.51C$1.471,000 shsC$115.33 million09/17/2025C$1.47C$1.50+2.04%C$1.51C$1.463,220 shsC$114.57 million09/16/2025C$1.52C$1.47-3.29%C$1.51C$1.471,300 shsC$112.28 million09/15/2025C$1.52C$1.52C$1.52C$1.52115 shsC$116.10 million09/12/2025C$1.51C$1.52+0.66%C$1.52C$1.52909 shsC$116.10 million09/11/2025C$1.50C$1.51+0.67%C$1.51C$1.511,240 shsC$115.33 million09/10/2025C$1.48C$1.50+1.35%C$1.50C$1.409,900 shsC$114.57 million09/09/2025C$1.45C$1.48+2.07%C$1.50C$1.48952 shsC$113.04 million09/08/2025C$1.45C$1.45C$1.48C$1.45236 shsC$110.75 million09/05/2025C$1.40C$1.45+3.57%C$1.45C$1.388,102 shsC$110.75 million Related Companies Fennec Pharmaceuticals Stock Chart Theratechnologies Stock Chart Medicenna Therapeutics Stock Chart Sernova Stock Chart Covalon Technologies Stock Chart Microbix Biosystems Stock Chart Resverlogix Stock Chart Devonian Health Group Stock Chart Hemostemix Stock Chart Innovotech Stock Chart Receive HBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:HBP) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
